Showing results (11-20 of 175) with videos related to
Sort By:
Pageof 18
Best Practice & Research. Clinical Haematology|November 4, 2022
Addressing symptom burden in myeloproliferative neoplasmsDouglas Tremblay, Ruben MesaTransactions of the American Clinical and Climatological Association|September 13, 2023
IMPROVING DIVERSE PARTICIPATION IN CANCER CLINICAL TRIALSRuben Mesa, Rebecca T JonesLeukemia Research|May 20, 2009
Hypothesis: how do JAK2-inhibitors work in myelofibrosisRuben Mesa, Robert Peter GaleCancer Journal (Sudbury, Mass.)|November 23, 2007
New and old treatment modalities in primary myelofibrosisFrancisco Cervantes, Ruben Mesa, Giovanni BarosiExpert Opinion on Pharmacotherapy|March 14, 2013
Polycythemia vera: current pharmacotherapy and future directionsBenjamin Hensley, Holly Geyer, Ruben MesaAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The role of JAK1/2 inhibitors in the treatment of chronic myeloproliferative neoplasmsClodagh Keohane, Ruben Mesa, Claire HarrisonLeukemia & Lymphoma|December 29, 2004
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasiaBrijesh Arora, Ruben Mesa, Ayalew TefferiAnnals of Hematology|April 3, 2015
Current and future treatment options for polycythemia veraMartin Griesshammer, Heinz Gisslinger, Ruben MesaNorth Carolina Medical Journal|October 7, 2024
The Persistent Three: Combating Heart Disease, Cancer, and Stroke in North CarolinaMelanie Phelps, Goldie Smith Byrd, Ruben MesaBlood|May 1, 2020
How I treat pain in hematologic malignancies safely with opioid therapyHolly L Geyer, Halena Gazelka, Ruben MesaPageof 18